Although FGF23 does not regulate and therefore does not affect transplacental Ca and P transport, its non-physiological increase in the mother induces hypophosphatemia, hypocalcemia, hypovitaminosis D, and secondary hyperparathyroidism. This evidence concerns the gene FGF23 and hypophosphatemia.